Ozempic approved to reduce cardiovascular risk Ozempic (semaglutide 0.5 mg, 1 mg, and 2 mg) previously received FDA approval for cardiovascular health in people with type 2 diabetes after combined results from the SUSTAIN-6 and PIONEER-6 trials showed a 24% reduction in major adverse cardiac events (MACE) such as heart attack, stroke, and other cardiovascular-related deaths
10.1210/en.2005-0545 74 HosomiK.SaitoM.ParkJ.MurakamiH.ShibataN.AndoM.et al (2022)
Rice, oatmeal, and plain potatoes provide starchy, binding carbohydrates that help solidify stool
Not every patient experiences weight loss on it, and for those who do, the results tend to be smaller than what GLP-1 medications produce in clinical trials
Zepbound is a subcutaneous injection prescribed for weight loss, weight management, and obstructive sleep apnea
As to the pain "going in" it may be that the needle caught a nerve or vein plus the fact that you were probably a little tense and nervous